Cormedix (CRMD) Stock Statistics & Valuation Metrics

Cormedix has a market cap or net worth of $921.06M. The enterprise value is $126.81M.

Cormedix has 67,824,660 shares outstanding. The number of shares has decreased by -2.65% in one year.

Cormedix’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is 0.06%.

The current PE Ratio of Cormedix is -26.60. Cormedix’s PEG ratio is 4.28.

In the last 12 months, Cormedix had revenue of 43.47M and earned -17.93M in profits. Earnings per share was -0.30.

In the last 12 months, operating cash flow was -13.57M and capital expenditures -64.60K, giving a free cash flow of -13.63M billion.

Cormedix pays an annual dividend of ―, resulting in a dividend yield of ―

Cormedix upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.

Cormedix as a current ratio of <0.01, with Debt / Equity ratio of -0.29%

In the past 12 months, Cormedix has paid -1.39M in taxes.

Cormedix EV to EBITDA ratio is -23.19, with an EV/FCF ratio of -8.61.

Cormedix has $77.50M in cash and marketable securities with $476.59K in debt, giving a net cash position of -$77.03M billion.

Gross margin is 94.29%, with operating margin of -51.43%, and net profit margin of -41.24%.

The average price target for Cormedix is $18.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy